Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary - Thomson StreetEvents

Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary

Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary - Thomson StreetEvents
Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary
Published Aug 05, 2021
14 pages (7027 words) — Published Aug 05, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of IOVA.OQ earnings conference call or presentation 5-Aug-21 8:30pm GMT

  
Brief Excerpt:

... (TIL) pipeline. 1. Reported clinical data across metastatic melanoma program, including first clinical data in early line melanoma, and new indications like metastatic non-small cell lung cancer. a. b. For lead TIL product candidate lifileucel and metastatic melanoma, top priority remains ongoing work to address FDA's feedback regarding potency assays for lifileucel to support planned BLA submission. c. Confident in ability to address FDA's feedback and complete work on additional assays in a timely manner. 2. Engaged ongoing dialog with FDA that Co. plans to continue through 2H21 to support BLA submission in 1H22 as guided. a. Resolution of potency assay is important next step towards progress in other late-stage clinical programs. B. Clinical Pipeline Updates: Has clinical data showing problems to TIL therapy in four different solid tumors space across various treatment settings, furthering confidence until broad platform and neck...

  
Report Type:

Brief

Source:
Company:
Iovance Biotherapeutics Inc
Ticker
IOVA.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Iovance Biotherapeutics Inc at Cowen Immuno-Oncology Next Summit (Virtual) Transcript – 2021-11-15 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 15-Nov-21 8:45pm GMT

Iovance Biotherapeutics Inc to Discuss SITC Clinical Data Updates Transcript – 2021-11-13 – US$ 54.00 – Edited Transcript of IOVA.OQ corporate analyst meeting</ 13-Nov-21 10:30pm GMT

Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary – 2021-11-04 – US$ 54.00 – Edited Brief of IOVA.OQ earnings conference call or presentation 4-Nov-21 8:30pm GMT

Iovance Biotherapeutics Inc Q3 2021 Earnings Call Transcript – 2021-11-04 – US$ 54.00 – Edited Transcript of IOVA.OQ earnings conference call or presentation 4-Nov-21 8:30pm GMT

Iovance Biotherapeutics Inc Q2 2021 Earnings Call Transcript – 2021-08-05 – US$ 54.00 – Edited Transcript of IOVA.OQ earnings conference call or presentation 5-Aug-21 8:30pm GMT

Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary – 2021-06-29 – US$ 54.00 – Edited Brief of IOVA.OQ conference call or presentation 29-Jun-21 8:30pm GMT

Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Transcript – 2021-06-29 – US$ 54.00 – Edited Transcript of IOVA.OQ conference call or presentation 29-Jun-21 8:30pm GMT

Iovance Biotherapeutics Inc at JMP Securities Life Sciences Virtual Conference Transcript – 2021-06-17 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 17-Jun-21 6:00pm GMT

Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-09 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 9-Jun-21 9:30pm GMT

Iovance Biotherapeutics Inc to Discuss Clinical Data for Lifileucel at ASCO Transcript – 2021-06-06 – US$ 54.00 – Edited Transcript of IOVA.OQ corporate analyst meeting</ 6-Jun-21 4:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary" Aug 05, 2021. Alacra Store. Apr 30, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Iovance-Biotherapeutics-Inc-Earnings-Call-B14926907>
  
APA:
Thomson StreetEvents. (2021). Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary Aug 05, 2021. New York, NY: Alacra Store. Retrieved Apr 30, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Iovance-Biotherapeutics-Inc-Earnings-Call-B14926907>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.